Forschungszentrum für Immuntherapie (FZI)
Forschungsschwerpunkt / Johannes Gutenberg-Universität Mainz
Regen, Tommy; Waisman, Ari
Modeling a complex disease: Multiple sclerosis-Update 2020Advances in Immunology. Bd. 149. 2021 S. 25-34
Wiendl, Heinz; Gold, Ralf; Berger, Thomas et al.
Multiple sclerosis treatment consensus group (MSTCG): position paper on disease-modifying treatment of multiple sclerosis 2021 (white paper)NERVENARZT. Bd. 92. H. 8. 2021 S. 773-801
Lang, Franziska; Ferreiro, Pablo Riesgo; Loewer, Martin et al.
NeoFox: annotating neoantigen candidates with neoantigen featuresBIOINFORMATICS. Bd. 37. H. 22. 2021 S. 4246-4247
Piepgras, Johannes; Mueller, Aneka; Steffen, Falk et al.
Neurofilament light chain levels reflect outcome in a patient with glutamic acid decarboxylase 65 antibody-positive autoimmune encephalitis under immune checkpoint inhibitor therapyEUROPEAN JOURNAL OF NEUROLOGY. Bd. 28. H. 3. 2021 S. 1086-1089
Muhammad, Khalid; Xavier, Delicia; Klein-Hessling, Stefan et al.
NFAT5 Controls the Integrity of EpidermisFRONTIERS IN IMMUNOLOGY. Bd. 12. 2021
Koenig, Anika; Vaeth, Martin; Chiarolla, Cristina Maria et al.
NFATc1/alpha A and Blimp-1 support the follicular and effector phenotype of murine TregsEUROPEAN JOURNAL OF IMMUNOLOGY. Bd. 51. 2021 S. 222-222
Uphaus, Timo; Steffen, Falk; Muthuraman, Muthuraman et al.
NfL predicts relapse-free progression in a longitudinal multiple sclerosis cohort studyEBIOMEDICINE. Bd. 72. 2021
Kavazovic, I.; Krapic, M.; Parga-Vidal, L. et al.
Obesity-induced memory CD8 T cell dysfunction in mice is independent of direct insulin signalingFEBS OPEN BIO. Bd. 11. 2021 S. 456-456
Rolfes, Leoni; Pawlitzki, Marc; Pfeuffer, Steffen et al.
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION. Bd. 8. H. 5. 2021
Lacki, Mateusz K.; Startek, Michal P.; Brehmer, Sven et al.
OpenTIMS, TimsPy, and TimsR: Open and Easy Access to timsTOF Raw DataJOURNAL OF PROTEOME RESEARCH. Bd. 20. H. 4. 2021 S. 2122-2129